Elevance Health, Inc.ELV
Market cap
$81.1B
P/E ratio
| 2010/12 | 2011/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | - | - | - | - | - | 1,154 | 1,302 | 1,675 | 1,393 |
| Stock-based compensation | 136 | 135 | 146 | 169 | 148 | 165 | 170 | 226 | 294 | 283 | 255 | 264 | 191 |
| Cash from operations | 1,417 | 3,374 | 3,052 | 3,369 | 4,116 | 3,205 | 4,185 | 3,827 | 6,061 | 10,688 | 8,364 | 8,399 | 5,808 |
| Capital expenditures | -451 | -519 | -646 | -715 | -638 | -584 | -799 | -1,208 | -1,077 | -1,021 | -1,087 | -1,152 | -1,256 |
| Cash from investing | -1,271 | -942 | -2,234 | -975 | -1,151 | -514 | -5,082 | -1,259 | -2,792 | -7,324 | -9,638 | -4,560 | -5,167 |
| Payments for dividends | - | 358 | 448 | 481 | 657 | 684 | 705 | 776 | 818 | 954 | 1,104 | 1,229 | 1,508 |
| Repurchases of common stock | 4,360 | 3,040 | 1,620 | 2,999 | 1,516 | - | 1,998 | 1,685 | 1,701 | 2,700 | 1,900 | 2,316 | 2,900 |
| Proceeds from issuance of term debt, net | 1,089 | 1,097 | 1,250 | 2,700 | 1,227 | - | 5,458 | 835 | 2,473 | 2,484 | 3,462 | 3,071 | 7,710 |
| Repayments of term debt | 482 | 705 | 1,802 | 1,730 | 2,697 | - | 2,815 | 1,684 | 1,123 | 1,932 | 1,068 | 1,899 | 1,650 |
| Cash from financing | -3,169 | -2,019 | -1,718 | -1,822 | -2,997 | -733 | 427 | -2,241 | -2,266 | -2,567 | 423 | -1,318 | 1,193 |
| Free cash flow | |||||||||||||
| FCF margin (%) |